2018-2023 Global Simply Drug Consumption Market Report

August 2018 | 164 pages | ID: 2E1A04F92C0EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Simply Drug market for 2018-2023.

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Over the next five years, LPI(LP Information) projects that Simply Drug will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Simply Drug market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Brand Drugs
• Generic Drug

Segmentation by application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Pfizer
• Roche
• Sanofi
• Johnson & Johnson
• Merck & Co. (MSD)
• Novartis
• AbbVie
• Gilead Sciences
• GlaxoSmithKline (GSK)
• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Eli Lilly
• Teva
• Bayer
• Novo Nordisk
• Allergan
• Shire
• Boehringer Ingelheim
• Takeda

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Simply Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Simply Drug market by identifying its various subsegments.
• Focuses on the key global Simply Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Simply Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Simply Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Simply Drug Consumption 2013-2023
  2.1.2 Simply Drug Consumption CAGR by Region
2.2 Simply Drug Segment by Type
  2.2.1 Brand Drugs
  2.2.2 Generic Drug
2.3 Simply Drug Consumption by Type
  2.3.1 Global Simply Drug Consumption Market Share by Type (2013-2018)
  2.3.2 Global Simply Drug Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Simply Drug Sale Price by Type (2013-2018)
2.4 Simply Drug Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 Simply Drug Consumption by Application
  2.5.1 Global Simply Drug Consumption Market Share by Application (2013-2018)
  2.5.2 Global Simply Drug Value and Market Share by Application (2013-2018)
  2.5.3 Global Simply Drug Sale Price by Application (2013-2018)

3 GLOBAL SIMPLY DRUG BY PLAYERS

3.1 Global Simply Drug Sales Market Share by Players
  3.1.1 Global Simply Drug Sales by Players (2016-2018)
  3.1.2 Global Simply Drug Sales Market Share by Players (2016-2018)
3.2 Global Simply Drug Revenue Market Share by Players
  3.2.1 Global Simply Drug Revenue by Players (2016-2018)
  3.2.2 Global Simply Drug Revenue Market Share by Players (2016-2018)
3.3 Global Simply Drug Sale Price by Players
3.4 Global Simply Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Simply Drug Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Simply Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 SIMPLY DRUG BY REGIONS

4.1 Simply Drug by Regions
  4.1.1 Global Simply Drug Consumption by Regions
  4.1.2 Global Simply Drug Value by Regions
4.2 Americas Simply Drug Consumption Growth
4.3 APAC Simply Drug Consumption Growth
4.4 Europe Simply Drug Consumption Growth
4.5 Middle East & Africa Simply Drug Consumption Growth

5 AMERICAS

5.1 Americas Simply Drug Consumption by Countries
  5.1.1 Americas Simply Drug Consumption by Countries (2013-2018)
  5.1.2 Americas Simply Drug Value by Countries (2013-2018)
5.2 Americas Simply Drug Consumption by Type
5.3 Americas Simply Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Simply Drug Consumption by Countries
  6.1.1 APAC Simply Drug Consumption by Countries (2013-2018)
  6.1.2 APAC Simply Drug Value by Countries (2013-2018)
6.2 APAC Simply Drug Consumption by Type
6.3 APAC Simply Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Simply Drug by Countries
  7.1.1 Europe Simply Drug Consumption by Countries (2013-2018)
  7.1.2 Europe Simply Drug Value by Countries (2013-2018)
7.2 Europe Simply Drug Consumption by Type
7.3 Europe Simply Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Simply Drug by Countries
  8.1.1 Middle East & Africa Simply Drug Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Simply Drug Value by Countries (2013-2018)
8.2 Middle East & Africa Simply Drug Consumption by Type
8.3 Middle East & Africa Simply Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Simply Drug Distributors
10.3 Simply Drug Customer

11 GLOBAL SIMPLY DRUG MARKET FORECAST

11.1 Global Simply Drug Consumption Forecast (2018-2023)
11.2 Global Simply Drug Forecast by Regions
  11.2.1 Global Simply Drug Forecast by Regions (2018-2023)
  11.2.2 Global Simply Drug Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Simply Drug Forecast by Type
11.8 Global Simply Drug Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Pfizer
  12.1.1 Company Details
  12.1.2 Simply Drug Product Offered
  12.1.3 Pfizer Simply Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Pfizer News
12.2 Roche
  12.2.1 Company Details
  12.2.2 Simply Drug Product Offered
  12.2.3 Roche Simply Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Roche News
12.3 Sanofi
  12.3.1 Company Details
  12.3.2 Simply Drug Product Offered
  12.3.3 Sanofi Simply Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Sanofi News
12.4 Johnson & Johnson
  12.4.1 Company Details
  12.4.2 Simply Drug Product Offered
  12.4.3 Johnson & Johnson Simply Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Johnson & Johnson News
12.5 Merck & Co. (MSD)
  12.5.1 Company Details
  12.5.2 Simply Drug Product Offered
  12.5.3 Merck & Co. (MSD) Simply Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Merck & Co. (MSD) News
12.6 Novartis
  12.6.1 Company Details
  12.6.2 Simply Drug Product Offered
  12.6.3 Novartis Simply Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Novartis News
12.7 AbbVie
  12.7.1 Company Details
  12.7.2 Simply Drug Product Offered
  12.7.3 AbbVie Simply Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 AbbVie News
12.8 Gilead Sciences
  12.8.1 Company Details
  12.8.2 Simply Drug Product Offered
  12.8.3 Gilead Sciences Simply Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Gilead Sciences News
12.9 GlaxoSmithKline (GSK)
  12.9.1 Company Details
  12.9.2 Simply Drug Product Offered
  12.9.3 GlaxoSmithKline (GSK) Simply Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 GlaxoSmithKline (GSK) News
12.10 Amgen
  12.10.1 Company Details
  12.10.2 Simply Drug Product Offered
  12.10.3 Amgen Simply Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Amgen News
12.11 AstraZeneca
12.12 Bristol-Myers Squibb
12.13 Eli Lilly
12.14 Teva
12.15 Bayer
12.16 Novo Nordisk
12.17 Allergan
12.18 Shire
12.19 Boehringer Ingelheim
12.20 Takeda

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Simply Drug
Table Product Specifications of Simply Drug
Figure Simply Drug Report Years Considered
Figure Market Research Methodology
Figure Global Simply Drug Consumption Grow